Design, strategies, and therapeutics in nanoparticle-based siRNA delivery systems for breast cancer
Changjiao Yan,Juliang Zhang,Meiling Huang,Jingjing Xiao,Nanlin Li,Ting Wang,Rui Ling
DOI: https://doi.org/10.1039/d3tb00278k
IF: 7.571
2023-07-19
Journal of Materials Chemistry B
Abstract:Utilizing small interfering RNA (siRNA) as a treatment for cancer, a disease largely driven by genetic aberrations, shows great promise. However, implementing siRNA therapy in clinical practice is challenging due to its limited bioavailability following systemic administration. An attractive approach to addresses this issue is the use of nanoparticle (NP) delivery platform, which protect siRNA and deliver it to the cytoplasm of target cells. We provide an overview of design considerations for using lipid-based NPs, polymer-based NPs, and inorganic NPs to improve the efficacy and safety of siRNA delivery. We focus on the chemical structure modification of carriers and NP formulation optimization, NP surface modifications to target breast cancer cells, as well as linking strategy and intracellular release of siRNA. As a practical example, recent advances in development of siRNA therapeutics for treating breast cancer are discussed, with a focus on inhibiting cancer growth, overcoming drug resistance, inhibiting metastasis, and enhancing immunotherapy.
materials science, biomaterials